PRE-FUNDED COMMON STOCK PURCHASE WARRANT GAIN THERAPEUTICS, Inc.Pre-Funded Common Stock Purchase Warrant • June 14th, 2024 • Gain Therapeutics, Inc. • Pharmaceutical preparations
THIS PRE-FUNDED COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, [___________________] or his assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) until this Warrant is exercised in full (the “Termination Date”) but not thereafter, to subscribe for and purchase from Gain Therapeutics, Inc., a company incorporated under the laws of the State of Delaware (the “Company”), up to [_________] shares of Common Stock (as subject to adjustment hereunder, the “Warrant Shares”). The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
REPRESENTATIVE’S PURCHASE WARRANT GAIN THERAPEUTICS, inc.Representative’s Purchase Warrant • June 14th, 2024 • Gain Therapeutics, Inc. • Pharmaceutical preparations
This REPRESENTATIVE’S PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _________________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date referred to above as the Initial Exercise Date (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on ____, 20293 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Gain Therapeutics, Inc, a Delaware corporation (the “Company”), up to _______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
SHARES OF COMMON STOCK (OR PRE-FUNDED WARRANTS IN LIEU THEREOF) GAIN THERAPEUTICS, INC. Underwriting AgreementUnderwriting Agreement • June 14th, 2024 • Gain Therapeutics, Inc. • Pharmaceutical preparations • New York
